We are a clinical stage pharma company focused on rare diseases caused by accelerated aging, DNA instability, accumulation of DNA damage, high sensitivity to oxidative stress and low telomerase activity.

We are developing new drugs and treatments to cure devastating diseases in the central nervous system, bone marrow, cardiovascular and pulmonary system among others.

Some o the diseases we are addressing are dyskeratosis congentita, ataxia telangiectasia and idiopathic pulmonary fibrosis.

contact us for more information.